Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pituitary Diseases × Dexamethasone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 672 Precursor Cell Lymphoblastic Leukemia-Lymphoma 144 Recurrence 107 Neoplasms, Plasma Cell 98 Leukemia 78 Lymphoma 74 Neoplasms 70 Vomiting 47 Burkitt Lymphoma 44 Lymphoma, Non-Hodgkin 41 Immunoglobulin Light-chain Amyloidosis 41 Lymphoma, Large B-Cell, Diffuse 33 Lymphoma, Mantle-Cell 31 Nausea 30 Prostatic Neoplasms 29 Lymphoma, Follicular 27 Waldenstrom Macroglobulinemia 26 Neoplasm Metastasis 23 Breast Neoplasms 23 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 22 Leukemia, Myeloid, Acute 22 Hodgkin Disease 22 Leukemia, Lymphocytic, Chronic, B-Cell 21 Carcinoma, Non-Small-Cell Lung 21 Lung Neoplasms 19 Amyloidosis 16 Lymphoma, Extranodal NK-T-Cell 14 Lymphoma, B-Cell, Marginal Zone 14 Leukemia, Biphenotypic, Acute 14 Colorectal Neoplasms 13

Interventions

Mifepristone 3 Corlux 3 Thyrotropin-Releasing Hormone 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Saline Solution 1 Radiotherapy 1 Radiomics 1 Nivolumab 1 LY2940680 1 Ipilimumab 1 Hydrocortisone 1 Dexmedetomidine 1 Dexamethasone 1 Biomarkers 1 Anesthesia, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02084134 2018-04-11

Steroid

Washington University School of Medicine

Phase NA Completed

43 enrolled 8 charts

Pituitary Diseases, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡